Equities analysts expect that Syneos Health Inc (NASDAQ:SYNH) will report $1.01 earnings per share for the current quarter, Zacks reports. Six analysts have made estimates for Syneos Health’s earnings. The highest EPS estimate is $1.03 and the lowest is $0.99. Syneos Health posted earnings per share of $0.95 during the same quarter last year, which would suggest a positive year over year growth rate of 6.3%. The business is scheduled to report its next earnings results on Monday, March 16th.
On average, analysts expect that Syneos Health will report full year earnings of $3.21 per share for the current fiscal year, with EPS estimates ranging from $3.19 to $3.23. For the next year, analysts anticipate that the company will report earnings of $3.63 per share, with EPS estimates ranging from $3.60 to $3.68. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that cover Syneos Health.
Syneos Health (NASDAQ:SYNH) last released its earnings results on Thursday, October 31st. The company reported $0.87 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.05. Syneos Health had a return on equity of 10.13% and a net margin of 1.86%. The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.18 billion. During the same period last year, the business posted $0.75 earnings per share. The business’s revenue for the quarter was up 5.6% on a year-over-year basis.
Several hedge funds and other institutional investors have recently made changes to their positions in SYNH. BB&T Corp grew its position in shares of Syneos Health by 8.1% in the second quarter. BB&T Corp now owns 8,749 shares of the company’s stock valued at $448,000 after purchasing an additional 656 shares in the last quarter. Arizona State Retirement System grew its position in Syneos Health by 1.6% during the second quarter. Arizona State Retirement System now owns 44,429 shares of the company’s stock worth $2,270,000 after buying an additional 697 shares in the last quarter. Financial Gravity Wealth Inc. purchased a new position in Syneos Health during the second quarter worth about $29,000. SG Americas Securities LLC grew its position in Syneos Health by 41.1% during the second quarter. SG Americas Securities LLC now owns 80,482 shares of the company’s stock worth $4,112,000 after buying an additional 23,454 shares in the last quarter. Finally, First Trust Advisors LP purchased a new position in Syneos Health during the second quarter worth about $5,423,000.
NASDAQ:SYNH traded up $0.22 during trading hours on Friday, reaching $55.53. The stock had a trading volume of 8,663 shares, compared to its average volume of 316,884. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.03 and a current ratio of 1.03. The stock has a 50 day simple moving average of $52.55 and a 200 day simple moving average of $50.73. Syneos Health has a 12-month low of $36.26 and a 12-month high of $56.34. The stock has a market cap of $5.76 billion, a P/E ratio of 21.27, a price-to-earnings-growth ratio of 1.88 and a beta of 1.50.
Syneos Health Company Profile
Syneos Health, Inc operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process.
See Also: Price-Sales Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.